What 3 parameters is the Model for End-Stage Liver Disease (MELD) score based on?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Model for End-Stage Liver Disease (MELD) Score Parameters

The MELD score is based on three objective laboratory parameters: international normalized ratio (INR), serum creatinine, and serum bilirubin. The correct answer is E.

Understanding the MELD Score Components

  • The Model for End-Stage Liver Disease (MELD) score was originally developed to assess short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunts (TIPS) 1
  • The MELD score incorporates three objective laboratory parameters: serum bilirubin, international normalized ratio (INR), and serum creatinine 1
  • These three parameters have been identified as the best predictors of 3-month mortality in patients with end-stage liver disease 1, 2
  • The MELD score assigns patients a continuous scale from 6 to 40, which correlates with estimated 3-month survival rates ranging from 90% to 7%, respectively 1

Clinical Applications of MELD Score

  • Since 2002, the MELD score has been used worldwide for liver allocation, prioritizing sicker patients first regardless of waiting time 3
  • A MELD score ≥15 is generally recommended as the threshold for listing patients for liver transplantation 1, 4
  • The MELD score has proven superior to the Child-Turcotte-Pugh (CTP) score in predicting 3-month mortality among patients on transplant waiting lists 5, 6
  • The area under the ROC curve for predicting 3-month mortality is 0.83 for MELD compared to 0.76 for the Child-Turcotte-Pugh score 6

Advantages of the MELD Score

  • The MELD score uses only objective criteria, unlike the Child-Pugh score which includes subjective assessments of encephalopathy and ascites 1, 2
  • Implementation of the MELD score in 2002 led to reduced mortality on liver transplant waiting lists without affecting post-transplant survival 2
  • The score can be calculated precisely and is not subject to interpretation, making it more reliable for organ allocation purposes 7
  • MELD has been validated as an accurate predictor of mortality in various clinical scenarios beyond transplantation, including alcoholic hepatitis, variceal hemorrhage, and surgery in cirrhotic patients 3

Limitations and Modifications

  • The MELD score has limitations in situations where INR or creatinine may be elevated due to reasons other than liver disease 2
  • Several variations of the original MELD score have been proposed, including MELD-Na (incorporating serum sodium) and Delta MELD (measuring change in MELD over time) 1
  • Certain conditions may not be adequately captured by the MELD score and require "exception points" in transplant allocation systems, such as hepatocellular carcinoma 1, 5
  • Quality assurance of MELD parameters is essential, as approximately 2.7% of MELD scores may not fulfill specified quality criteria 7

Comparison with Other Scoring Systems

  • The Child-Turcotte-Pugh score includes five parameters: encephalopathy, ascites, bilirubin, albumin, and prothrombin time/INR 1
  • While the Child-Pugh score is useful for rapid assessment of relative mortality risk, it has never been formally validated as a prognostic tool 1
  • The MELD score has demonstrated superior accuracy in predicting short-term mortality compared to the Child-Pugh score 6
  • Unlike the Child-Pugh score, the MELD score includes renal function (serum creatinine), which is an important prognostic marker in patients with liver disease 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.